CytoSorbents Awarded $1.5 Million Sequential Phase II SBIR Contract to Advance the Treatment of Severe Hyperkalemia in Traumatic Injury
Stock Information for CytoSorbents Corporation
Loading
Please wait while we load your information from QuoteMedia.